[go: up one dir, main page]

SE8107468L - Komposition for behandling av psoriasis pa basis av en 1,8-dihydroxi-9-antron substituerad i 10-stellningen - Google Patents

Komposition for behandling av psoriasis pa basis av en 1,8-dihydroxi-9-antron substituerad i 10-stellningen

Info

Publication number
SE8107468L
SE8107468L SE8107468A SE8107468A SE8107468L SE 8107468 L SE8107468 L SE 8107468L SE 8107468 A SE8107468 A SE 8107468A SE 8107468 A SE8107468 A SE 8107468A SE 8107468 L SE8107468 L SE 8107468L
Authority
SE
Sweden
Prior art keywords
treatment
composition
dihydroxi
antron
substituted
Prior art date
Application number
SE8107468A
Other languages
Unknown language ( )
English (en)
Other versions
SE453961B (sv
Inventor
B Shroot
J Maignan
G Lang
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of SE8107468L publication Critical patent/SE8107468L/sv
Publication of SE453961B publication Critical patent/SE453961B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SE8107468A 1980-12-15 1981-12-14 Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden SE453961B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8026550A FR2495934A1 (fr) 1980-12-15 1980-12-15 Composition pour le traitement du psoriasis a base d'une dihydroxy-1,8 anthrone-9 substituee en position 10

Publications (2)

Publication Number Publication Date
SE8107468L true SE8107468L (sv) 1982-06-16
SE453961B SE453961B (sv) 1988-03-21

Family

ID=9249080

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107468A SE453961B (sv) 1980-12-15 1981-12-14 Anvendning av substituerad 1,8-dihydroxi-9-antron for framstellning av ett lekemedel for behandling av psoriasis genom anbringande pa huden

Country Status (11)

Country Link
US (1) US4405615A (sv)
JP (1) JPS57163311A (sv)
BE (1) BE891467A (sv)
CA (1) CA1186228A (sv)
CH (1) CH649708A5 (sv)
DE (1) DE3149528C2 (sv)
FR (1) FR2495934A1 (sv)
GB (1) GB2091999B (sv)
IT (1) IT1142097B (sv)
NL (1) NL8105618A (sv)
SE (1) SE453961B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565966B1 (fr) * 1984-06-13 1986-08-29 Cird Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2567402B1 (fr) * 1984-07-12 1988-07-01 Cird Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
AU628304B2 (en) * 1987-10-22 1992-09-17 Victoria University Of Manchester, The New compounds of the anthraquinone series
EP0586479A1 (en) * 1991-05-29 1994-03-16 Pfizer Inc. Dihydroxyindanone tyrosine kinase inhibitors
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
DK0934078T3 (da) * 1996-10-24 2003-04-14 Alza Corp Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
JP2007513173A (ja) * 2003-12-03 2007-05-24 スミスクライン・ビーチャム・コーポレイション ロシグリタゾンを用いる乾癬の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256663A1 (de) * 1972-11-18 1974-05-22 Basf Ag Verfahren zur herstellung von chloranthrachinon-2,3-dicarbonsaeureanhydriden
US3835167A (en) * 1972-12-18 1974-09-10 Syntex Inc Anthrone carboxylic acids and derivatives

Also Published As

Publication number Publication date
CA1186228A (fr) 1985-04-30
US4405615A (en) 1983-09-20
JPS57163311A (en) 1982-10-07
FR2495934A1 (fr) 1982-06-18
DE3149528A1 (de) 1982-08-19
DE3149528C2 (de) 1985-10-31
IT1142097B (it) 1986-10-08
NL8105618A (nl) 1982-07-01
CH649708A5 (fr) 1985-06-14
GB2091999B (en) 1984-08-15
FR2495934B1 (sv) 1983-06-17
SE453961B (sv) 1988-03-21
GB2091999A (en) 1982-08-11
BE891467A (fr) 1982-06-14
IT8125582A0 (it) 1981-12-14

Similar Documents

Publication Publication Date Title
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
ES2067314T3 (es) 3-benzacepin-zonas sustituidas por un grupo benzociclobutilo o indanil-alquil-amino-alquilo, utiles en el tratamiento de las afecciones cardiovasculares.
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
FI972580A (sv) Preparat och förfaranden för minskande av hudirritation
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
AU583055B2 (en) Tetralin derivatives, their preparation and their use
ES2154266T3 (es) Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico y su empleo como medicamentos.
AU531057B2 (en) 6beta,7beta,15,16-dimethylene-1,4-androstadien-3-ones
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ES2072784T3 (es) Benzo- y piridopiridonas substituidas con sulfonilbencilo.
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
ATE30583T1 (de) Vitamin-d3-derivate.
SE8107468L (sv) Komposition for behandling av psoriasis pa basis av en 1,8-dihydroxi-9-antron substituerad i 10-stellningen
AU541413B2 (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
BE886370A (fr) Derives de l'acide 16-hydroxy-prostanoique 4,5-insatures
SE8303700D0 (sv) Terapeutisk komposition
BR8104364A (pt) Composicoes reguladoras de crescimento vegetal,baseadas em derivados do triazol
AU568064B2 (en) 4-acylamino-1-aza-adamantanes
ES2058196T3 (es) Derivados de azacromano.
FI960588A0 (sv) Tiokarbamoylföreningar användbara som mikrobicider
ES2051765T3 (es) 13 alfa-alquilgon-delta9(11)-en-5,10-epoxidos.
JPS51123824A (en) A non-medical antibacterial and its preparation
ES8106156A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
JPS53137934A (en) Novel cyclic saturated sestaterpenes

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8107468-4

Effective date: 19930709

Format of ref document f/p: F